#United States #New York #Gross Law Firm #MLTX #MoonLake Immunotherapeutics

Summary of the Class Action Notice

The Gross Law Firm has released an important notice for shareholders of MoonLake Immunotherapeutics (NASDAQ: MLTX). The firm emphasizes the significance of this notice amid concerns regarding a potential class action lawsuit that is currently underway. Investors who purchased shares during a specified class period are urged to contact the firm for further details and guidance on possible involvement in the case.

Class Period Details

The designated class period outlined by the law firm runs from March 10, 2024, to September 29, 2025. This timeframe is critical for shareholders interested in understanding their legal rights and opportunities for potential recovery. The allegations pertain to multiple misleading statements made by the defendants concerning the company's drug candidate, SLK, as well as its comparison to BIMZELX. For shareholders, being informed about these details is essential to making timely and informed decisions.

Allegations Against the Company

The allegations in the complaint suggest that the company has issued materially false and/or misleading statements, as well as having failed to disclose crucial information related to their product SLK. This includes the assertion that SLK and BIMZELX share the same molecular targets, and that SLK’s unique Nanobody structure does not provide the clinical benefits previously claimed. Moreover, it suggests that SLK's supposed advantages concerning tissue penetration do not lead to clinical efficacy, undermining the basis for optimistic statements about its superiority compared to traditional monoclonal antibodies.

Next Steps for Shareholders

Shareholders wishing to participate in this class action are urged not to delay in registering their information. The law firm has set a deadline of December 15, 2025, for shareholders to seek appointment as lead plaintiffs in this action. Importantly, those who register will benefit from access to portfolio monitoring software, which will keep them informed about the case's progression.

The Gross Law Firm's Commitment

The Gross Law Firm is a nationally recognized entity that specializes in class action lawsuits, operating with the mission to safeguard the rights of investors who have suffered losses due to deceptive and illegal practices by corporations. Their dedication to ensuring companies adhere to ethical standards and engage in responsible business practices is at the core of their operation. They strive to facilitate recovery for investors impacted by misleading statements or omissions that contribute to inflated stock prices.

Contact Information

It is crucial for affected shareholders to get in touch with The Gross Law Firm to initiate their participation in the class action lawsuit. Interested parties can contact the firm directly:

• - Address: 15 West 38th Street, 12th floor, New York, NY, 10018
• - Email: [email protected]
• - Phone: (646) 453-8903

This notice serves as a crucial moment for shareholders of MoonLake Immunotherapeutics, allowing them to assert their rights and seek redress for their financial losses effectively. The deadline for action is approaching, and stakeholders are encouraged to act promptly to protect their interests.